Company News
Enterprise Honor
Corporate Policy

Home / News / Company News / Century 3 Participated in BioPharm Frontier Technology & Regulatory Policy Conference

Century 3 Participated in BioPharm Frontier Technology & Regulatory Policy Conference

Author: Century 3       Update: 2020-07-14


From 10th to 11th July, Century 3 has participated in the 2nd BioPharm Frontier Technology & Regulatory Policy Conference held at Suzhou Industrial Park as an exhibitor. The conference created a robust exchange of ideas on pharmaceutical innovation and industrialization of drugs among over 1,500 biomedical scholars and executives from major pharmaceutical companies.


 
....

The main conference and eight panel discussions following the opening ceremony have attracted attendance by a slew of industrial experts. The themes covered trending topics including drug target development, antibody drug development, CAR-T therapy, gene editing, small molecule drugs, investment and supply chain of pharmaceutical industry, etc.

 
....

As a trusted advisor for pharmaceutical and life science clients in China, Century 3 has provided full life-cycle services from planning, design, highly tuned process engineering consultancy to construction management and construction to many renowned pharmaceutical clients. Through participating in this conference, we have strengthened communication with our target clients, hoping to serve more clients for projects ranging from medical device manufacturing, early stage discovery research to development and commercialization.